Acute Peripheral Neuropathy in the Emergency Department: High-Yield FRCEM SBA Practice Questions Explained

FRCEM SBA practice questions is a core part of UK Emergency Medicine practice. Acute peripheral neuropathy is a clinically compelling and examinable topic that sits at the intersection of neurological acuity and emergency resuscitation. In UK emergency departments, the failure to recognise Guillain-Barre syndrome (GBS) in its early stages remains a recognised cause of preventable respiratory arrest, making this a priority condition in both clinical practice and FRCEM SBA exam preparation. The RCEM curriculum explicitly maps acute neuromuscular presentations to the emergency medicine competency framework, and question writers consistently exploit the subtleties of peripheral versus central neurological differentiation, respiratory monitoring thresholds, and immunotherapy decision-making. Candidates who treat this topic superficially risk losing marks on stems that reward precise mechanistic and management knowledge.

Clinical Context and Epidemiology

Acute peripheral neuropathy encompasses disorders characterised by rapid onset of weakness, sensory disturbance, or autonomic dysfunction arising from damage to peripheral nerves, nerve roots, or both. The breadth of the differential spans benign compressive mononeuropathies to genuinely life-threatening polyradiculoneuropathies. GBS has an annual incidence of approximately 1 to 2 per 100,000 in the United Kingdom and is the most important acute peripheral neuropathy presenting to the ED. Chronic inflammatory demyelinating polyneuropathy (CIDP) may also decompensate acutely. Other aetiologies of clinical and examinable relevance include vasculitic neuropathy, toxic and drug-induced neuropathy, metabolic causes, and infective triggers such as Lyme disease and post-viral syndromes.

The aetiological framework that FRCEM SBA practice questions most often probe can be structured as follows. Immune-mediated causes include GBS in its several subtypes (AIDP, AMAN, AMSAN, and Miller Fisher syndrome), CIDP relapse, and vasculitic neuropathy associated with polyarteritis nodosa or ANCA-associated vasculitis. Infective triggers encompass post-Campylobacter jejuni illness, EBV, CMV, SARS-CoV-2, Lyme disease, diphtheria, and HIV. Toxic and drug-induced neuropathies arise from alcohol, heavy metals (lead, arsenic, thallium), chemotherapy agents such as vincristine and cisplatin, isoniazid, nitrofurantoin, and nitrous oxide via B12 depletion. Metabolic and nutritional causes include acute painful diabetic neuropathy, thiamine deficiency, B12 deficiency, and uraemic neuropathy. Hereditary conditions in acute decompensation, particularly acute intermittent porphyria, are classic SBA question fodder given their dramatic and often misdiagnosed presentations.

Understanding the epidemiology matters for exam purposes because GBS question stems frequently embed a prodromal illness 2 to 4 weeks before neurological onset. Campylobacter jejuni is the most commonly identified antecedent organism and is associated with the axonal subtypes (AMAN and AMSAN), which tend to have a more severe clinical course. Recognising this temporal pattern is often the discriminating feature in an SBA stem. Further guidance on acute neurological presentations in the ED can be found through the Royal College of Emergency Medicine, whose curriculum documentation outlines the expected competencies for managing these cases.

Pathophysiology at Registrar Level

In the commonest GBS subtype, acute inflammatory demyelinating polyneuropathy (AIDP), molecular mimicry drives the pathology. Antibodies generated against a preceding infective agent cross-react with ganglioside epitopes on peripheral nerve myelin, activating complement and recruiting macrophages to strip the myelin sheath from axons. The result is conduction block that manifests clinically as flaccid weakness, areflexia, and sensory loss before overt axonal loss has occurred. Because the process is initially demyelinating rather than axonal, recovery can be rapid and complete if the inflammatory process is arrested promptly, which is the mechanistic rationale for IVIg and plasma exchange.

Axonal subtypes (AMAN and AMSAN) differ in that the immune attack targets the axonal membrane directly, mediated by anti-ganglioside antibodies (particularly anti-GM1 and anti-GD1a). These subtypes carry a higher risk of prolonged or incomplete recovery. Miller Fisher syndrome, characterised by the triad of ophthalmoplegia, ataxia, and areflexia, is associated with anti-GQ1b antibodies and is frequently tested in FRCEM SBA exam questions because its cranial nerve predominance makes it a plausible mimic of a central lesion. Recognising that Miller Fisher syndrome is a peripheral process, supported by the presence of areflexia and the specific antibody, is a high-yield discriminator.

The autonomic nervous system involvement in GBS deserves specific mention. Sympathetic and parasympathetic dysfunction produces a volatile and unpredictable cardiovascular environment: sinus tachycardia, bradycardia precipitated by suctioning or Valsalva, hypertensive surges, and hypotensive episodes may all occur. This autonomic instability is a major cause of in-hospital mortality and directly informs the decision to manage these patients in a high-dependency or intensive care environment even before respiratory compromise is evident.

ED Assessment and Management

History and Examination

A directed history should establish the tempo and pattern of weakness (ascending versus descending, proximal versus distal, symmetrical versus asymmetrical), presence of sensory symptoms, autonomic features (palpitations, urinary retention, constipation, postural dizziness), and any prodromal illness in the preceding 2 to 4 weeks. Ask specifically about recent gastroenteritis, upper respiratory tract infection, and any vaccination history, as post-vaccination GBS, though rare, is examinable. Drug history must include nitrous oxide exposure, isoniazid use (particularly in TB treatment without pyridoxine supplementation), and chemotherapy agents.

Examination should document the distribution and severity of weakness using the Medical Research Council (MRC) scale, deep tendon reflexes (classically absent or diminished in GBS), cranial nerve involvement, and a clear assessment of respiratory muscle function. The absence of upper motor neurone signs (hyperreflexia, upgoing plantars, spasticity) is the critical feature distinguishing peripheral from central pathology. Bowel and bladder function should be assessed; incontinence with bilateral lower limb weakness raises the possibility of a spinal cord lesion rather than GBS and necessitates urgent MRI.

Investigations

Bedside spirometry is the single most important investigation in a patient with suspected GBS presenting to the ED. The 20-30-40 rule, derived from clinical observation and supported by published neurocritical care guidance, states that FVC below 20 ml/kg, maximum inspiratory pressure (MIP) below 30 cmH2O, or maximum expiratory pressure (MEP) below 40 cmH2O should prompt urgent ICU review and preparation for intubation. Waiting for arterial blood gas deterioration is a dangerous and examinable error: hypoxia and hypercapnia are late signs in neuromuscular respiratory failure.

Blood investigations should include full blood count, inflammatory markers, renal and liver function, blood glucose, B12 and folate, thyroid function, and vasculitis screen (ANCA, ANA) where clinically appropriate. Heavy metal screen and porphyrin screen (urine delta-aminolaevulinic acid and porphobilinogen) should be requested when the history raises acute intermittent porphyria or toxic exposure. Cerebrospinal fluid analysis, performed after neurological consultation, classically demonstrates cytoalbuminous dissociation in GBS: elevated protein with a normal or near-normal white cell count. Anti-ganglioside antibody titres (anti-GM1, anti-GQ1b) support specific GBS subtype diagnosis but are not typically available during the ED attendance and should not delay management. Nerve conduction studies, similarly, are arranged following admission and specialist review.

ECG and continuous cardiac monitoring are essential given the risk of autonomic arrhythmia. Neuroimaging (MRI brain and spine) is indicated when the clinical picture does not clearly support a peripheral diagnosis or when upper motor neurone signs, sphincter disturbance, or a distinct spinal level is identified on examination, as recommended by NICE guidance on acute neurological presentations.

Management Algorithm

Airway, breathing, and circulation take precedence. Any patient with FVC below 20 ml/kg, a rapidly declining trend on serial spirometry, or bulbar dysfunction should be discussed immediately with intensive care. Elective intubation before crisis is safer than emergency intubation in the context of haemodynamic instability and aspiration risk. IVIg (0.4 g/kg/day for 5 days) or plasma exchange are the definitive immunotherapies and should be initiated following neurological confirmation of the diagnosis, not in the ED as a de novo decision. Steroids, including methylprednisolone, confer no benefit in GBS and may worsen outcome; this is a classic exam trap.

Pain management is often underappreciated. Neuropathic pain in GBS can be severe; neuropathic agents such as gabapentin or pregabalin, alongside opioids where required, are appropriate adjuncts. Deep vein thrombosis prophylaxis, pressure area care, urinary catheterisation if retention is present, and nasogastric feeding for those with bulbar dysfunction are all part of the acute care bundle. The BMJ’s clinical review literature on GBS provides a concise synthesis of these management principles that trainees preparing for the FRCEM SBA exam will find useful.

How the FRCEM SBA Exam Tests This Topic

The FRCEM SBA exam tests acute peripheral neuropathy across several question archetypes that are worth anticipating in your FRCEM SBA revision. The first is the diagnostic discrimination question: a patient presents with bilateral lower limb weakness and the stem includes a subtle clue (absent reflexes versus hyperreflexia, or sensory level versus glove-and-stocking loss) that determines whether the answer is GBS or transverse myelitis. Missing the reflex finding in the stem is the most common error candidates report.

The second archetype is the investigation priority question. A stem describes worsening weakness and asks what single investigation should be performed immediately: the correct answer is bedside spirometry (FVC measurement), not MRI, not LP, not blood gas. Understanding the rationale (neuromuscular respiratory failure is a pre-hypoxic process) is what distinguishes a pass from a distinction-level answer.

The third common archetype involves treatment selection. A stem presents a confirmed GBS patient and asks which treatment is most appropriate: IVIg and plasma exchange are both correct; steroids are incorrect. Question writers may include combined IVIg plus plasma exchange as a distractor (evidence does not support combination therapy). Porphyria stems typically present a young patient with abdominal pain, psychiatric disturbance, and ascending neuropathy, often with a history of precipitant drug use; the question asks for the urine investigation to confirm the diagnosis.

The RCEM curriculum maps these competencies under the acute medicine and critical care domains. Candidates using FRCEM Single Best Answer revision course at EM Learning Centre will find dedicated question banks targeting these exact stem structures, with detailed explanations grounded in UK clinical guidelines.

Revision Pearls: High-Yield Facts for the FRCEM SBA

1. GBS has an annual UK incidence of 1 to 2 per 100,000 and is the leading cause of acute flaccid paralysis in the post-polio era.
2. The 20-30-40 rule (FVC below 20 ml/kg, MIP below 30 cmH2O, MEP below 40 cmH2O) defines the respiratory threshold for ITU escalation; hypoxia on blood gas is a late and dangerous sign.
3. Miller Fisher syndrome (ophthalmoplegia, ataxia, areflexia) is associated with anti-GQ1b antibodies and is a peripheral, not central, diagnosis despite its cranial nerve presentation.
4. CSF cytoalbuminous dissociation (raised protein, normal white cells) is the characteristic CSF finding in GBS but may be normal in the first week of illness.
5. Steroids are not beneficial in GBS and should not be prescribed; IVIg and plasma exchange are equivalent and neither is superior when combined.
6. Acute intermittent porphyria presents with abdominal pain, psychiatric features, and ascending neuropathy; urine porphobilinogen (PBG) is the diagnostic investigation and precipitants include many common drugs including antiepileptics and sulphonamides.
7. Autonomic dysfunction in GBS (cardiac arrhythmia, labile blood pressure) can be fatal independently of respiratory failure and mandates continuous ECG monitoring.
8. Post-Campylobacter GBS is associated with axonal subtypes (AMAN and AMSAN) and a more severe, slower recovery compared to AIDP.

Common Pitfalls: Where Candidates Lose Marks

• Anchoring on central pathology when the stem clearly states absent reflexes, which are incompatible with an upper motor neurone lesion.
• Ordering MRI as the first investigation in a patient with progressive GBS weakness rather than prioritising spirometry to assess for impending respiratory failure.
• Prescribing corticosteroids for GBS, a persistent and heavily penalised error that contradicts high-quality randomised trial evidence.
• Missing the autonomic features in a GBS stem and failing to select continuous cardiac monitoring as a required management step.
• Confusing Miller Fisher syndrome with a brainstem stroke because of the ophthalmoplegia, when the absence of other central signs and presence of areflexia indicate a peripheral aetiology.
• Failing to identify the prodrome in a GBS stem, particularly a history of diarrhoea 3 weeks prior, which is the key contextual clue the examiner has deliberately placed.

How EM Learning Centre Supports Your FRCEM Single Best Answer Revision

Acute peripheral neuropathy is precisely the kind of topic where candidates believe they understand the material until they encounter a carefully constructed SBA stem that exploits exactly the gaps described above. Systematic, question-led revision with detailed explanations is the most efficient way to close those gaps before sitting the FRCEM SBA exam. The EM Learning Centre homepage provides access to a structured suite of FRCEM SBA practice questions spanning neurology, critical care, toxicology, and the full breadth of the emergency medicine curriculum, each accompanied by referenced explanations written at consultant level.

Our FRCEM Single Best Answer revision course at EM Learning Centre is built around the RCEM curriculum framework and mirrors the cognitive demands of the real examination, giving candidates repeated exposure to the stem structures, distractors, and clinical reasoning chains that determine performance on the day. For trainees at any stage of preparation, targeted question practice on high-yield topics such as acute peripheral neuropathy represents some of the highest-return revision time available in the weeks before the FRCEM SBA exam.

References

1. Royal College of Emergency Medicine. Emergency Medicine Curriculum and Assessment Framework. rcem.ac.uk
2. National Institute for Health and Care Excellence. Guidance on neurological conditions and acute presentations. nice.org.uk
3. BMJ Clinical Evidence and Review. Guillain-Barre syndrome: clinical management and evidence base. bmj.com
4. RCEM Learning. Clinical education resources for emergency medicine trainees. rcemlearning.co.uk
5. Resuscitation Council UK. Advanced Life Support and critical care guidance. resus.org.uk